Tigatuzumab (CS-1008)

From HemOnc.org - A Hematology Oncology Wiki
Jump to: navigation, search

Mechanism of action

Monoclonal antibody directed against the tumour necrosis factor-related apoptosis-inducing ligand receptor 2 (TRAIL-R2)

Also known as

  • Code name: CS-1008